Purchase this article with an account.
Timothy W Corson; High throughput screening for bioactive compound discovery. Invest. Ophthalmol. Vis. Sci. 2018;59(9):2580. doi: https://doi.org/.
Download citation file:
© ARVO (1962-2015); The Authors (2016-present)
Presentation Description :
Small molecules can be powerful probes for biological pathways and potential therapeutic leads. High throughput screening offers potential for identifying compounds with desired bioactivities, and has been applied in varied areas of vision science. However, designing, running, and interpreting screens requires careful planning to yield useful results. In this session, I will discuss some of these challenges and best practices for success, using examples of both target-based and cell-based screens from ophthalmic research.
This is an abstract that was submitted for the 2018 ARVO Annual Meeting, held in Honolulu, Hawaii, April 29 - May 3, 2018.
This PDF is available to Subscribers Only